Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Response”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03893565
What this trial is testing

Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline 104
Early research (Phase 1)Study completedNCT02767089
What this trial is testing

The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers

Who this might be right for
Healthy Adults
Pfizer 37
Testing effectiveness (Phase 2)Ended earlyNCT05781750
What this trial is testing

Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Who this might be right for
Lupus Nephritis
Kezar Life Sciences, Inc. 84
Early research (Phase 1)Study completedNCT04911127
What this trial is testing

Therapeutic Response of Cannabidiol in Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisCannabis
University of California, Los Angeles 67
Large-scale testing (Phase 3)Study completedNCT01199861
What this trial is testing

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis 138
Large-scale testing (Phase 3)Study completedNCT06614725
What this trial is testing

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 751
Testing effectiveness (Phase 2)Study completedNCT06306742
What this trial is testing

Open-label Placebo in Manual Therapy

Who this might be right for
Low Back Pain, Recurrent
Studio Osteopatico Busto Arsizio 31
Testing effectiveness (Phase 2)UnknownNCT00294788
What this trial is testing

Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines

Who this might be right for
Influenza
Probiomics Ltd 300
Testing effectiveness (Phase 2)Study completedNCT04418089
What this trial is testing

Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer

Who this might be right for
Breast CancerChemotherapy Effect
Universitas Indonesia 60
Testing effectiveness (Phase 2)Looking for participantsNCT04550377
What this trial is testing

Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI

Who this might be right for
Post Traumatic Stress DisorderTraumatic Brain Injury
NYU Langone Health 120
Large-scale testing (Phase 3)Study completedNCT00344149
What this trial is testing

Rituximab as Second Line Treatment for ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Ostfold Hospital Trust 112
Large-scale testing (Phase 3)Study completedNCT02308163
What this trial is testing

Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 509
Early research (Phase 1)Looking for participantsNCT07698600
What this trial is testing

A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

Who this might be right for
HIV -1 Infection
BioNTech SE 126
Early research (Phase 1)Study completedNCT05163834
What this trial is testing

Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV

Who this might be right for
Healthy Volunteers
argenx 36
Post-approval studies (Phase 4)Study completedNCT02523287
What this trial is testing

Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses

Who this might be right for
Safety Markers of Adjuvanted Influenza Vaccine
University Hospital, Ghent 240
Large-scale testing (Phase 3)WithdrawnNCT07492875
What this trial is testing

Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia

Who this might be right for
Community-Acquired Pneumonia (CAP)Acute Respiratory Distress Syndrome (ARDS)Sepsis+2 more
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Study completedNCT00012467
What this trial is testing

Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
InterMune 60
Not applicableStudy completedNCT02941809
What this trial is testing

Harnessing Placebo Effects in Methadone Treatment

Who this might be right for
Opioid-use DisorderOpioid-Related Disorders
University of Maryland, Baltimore 133
Testing effectiveness (Phase 2)Study completedNCT02805439
What this trial is testing

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Who this might be right for
Major Depressive Disorder
Institut de Recherches Internationales Servier 400
Testing effectiveness (Phase 2)Study completedNCT00158899
What this trial is testing

GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol

Who this might be right for
DyslipidaemiasDyslipidaemia
GlaxoSmithKline 424
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation